CELLCOMB AB

Their core work

CELLCOMB AB is a Swedish SME developing bio-based absorbent pads for food packaging — the small absorbent sheets placed inside meat, fish, and poultry trays to soak up liquid and extend shelf life. Their CellSorb technology replaces conventional synthetic pads (typically made from petrochemical superabsorbent polymers) with a cellulose-derived alternative that is both food-safe and cost-competitive. The company progressed from a Phase 1 feasibility study to a full Phase 2 commercialization grant under the EU SME Instrument, indicating validated market potential and a credible path to production. Their value proposition sits at the intersection of sustainable packaging, food safety, and cost reduction for food processors and retailers.

What they specialise in

How they've shifted over time

CELLCOMB AB's entire H2020 history is a single product development arc — the CellSorb food pad — moving from feasibility (SME-1, 2019) to full commercialization funding (SME-2b, 2020–2022). There is no keyword shift or thematic pivot to analyze because the company pursued one tightly focused innovation through both phases. This is not a weakness: it signals a company that defined a specific market problem, validated it with EU funding, and executed a disciplined commercialization path rather than spreading across multiple research threads.

CELLCOMB AB is on a commercialization trajectory with a single, well-funded product; any future EU engagement would likely involve manufacturing scale-up, market entry in new geographies, or extensions into adjacent food packaging formats.

How they like to work

CELLCOMB AB operated as a solo entity through the EU SME Instrument, which was specifically designed for single companies rather than consortia — so the absence of listed partners reflects the funding structure, not necessarily a preference for isolation. As the coordinator of both projects, they have demonstrated ability to manage EU grant obligations independently. For future consortium projects (e.g., Horizon Europe partnerships), they would most likely contribute as a specialist industry partner bringing a near-market technology rather than as a scientific research lead.

Under the SME Instrument mechanism, CELLCOMB AB operated without formal consortium partners, which is typical for that funding scheme. Their documented EU collaboration footprint is limited to Sweden, with no recorded cross-border partnerships in the H2020 data.

What sets them apart

CELLCOMB AB occupies a specific and commercially relevant niche: they are not a research lab experimenting with bio-materials, but an SME with a funded, near-market product targeting a high-volume segment of the food packaging industry. The combination of food safety focus and cost-efficiency framing sets them apart from academic bio-material researchers who rarely address production economics. For partners in the food sector, retailer supply chains, or sustainable packaging initiatives, CELLCOMB offers a concrete technology at a stage where industrial pilots and supplier agreements are the logical next step.

Highlights from their portfolio

• CellSorb (Phase 2)
  With €2.3M in EC funding, this is the primary commercialization vehicle — one of the largest single-company SME Instrument Phase 2 grants, signalling strong evaluator confidence in the technology and market case.
• CellSorb (Phase 1)
  The €50k feasibility phase that preceded and unlocked the Phase 2 grant, demonstrating a validated step-by-step EU funding strategy from concept to commercialization.